Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Accumulated Expenses: 2018-2025

Historic Accumulated Expenses for Verastem (VSTM) over the last 8 years, with Sep 2025 value amounting to $44.7 million.

  • Verastem's Accumulated Expenses rose 101.87% to $44.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.7 million, marking a year-over-year increase of 101.87%. This contributed to the annual value of $26.0 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Verastem's Accumulated Expenses is $44.7 million, which was up 17.27% from $38.1 million recorded in Q2 2025.
  • In the past 5 years, Verastem's Accumulated Expenses ranged from a high of $44.7 million in Q3 2025 and a low of $8.8 million during Q1 2021.
  • Moreover, its 3-year median value for Accumulated Expenses was $19.8 million (2024), whereas its average is $23.5 million.
  • In the last 5 years, Verastem's Accumulated Expenses crashed by 51.09% in 2021 and then skyrocketed by 121.79% in 2025.
  • Over the past 5 years, Verastem's Accumulated Expenses (Quarterly) stood at $15.6 million in 2021, then dropped by 4.08% to $15.0 million in 2022, then increased by 10.32% to $16.3 million in 2023, then surged by 35.79% to $26.0 million in 2024, then soared by 101.87% to $44.7 million in 2025.
  • Its Accumulated Expenses was $44.7 million in Q3 2025, compared to $38.1 million in Q2 2025 and $25.4 million in Q1 2025.